Fate Therapeutics to present FT819 Encore clinical data at CCR West 2026
Fate Therapeutics said it will present encore clinical data for its FT819 off-the-shelf CAR T-cell product candidate at the CCR West 2026 meeting.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.